Marker Therapeutics Inc (MRKR)

[microcapbiotech]

"The trial is expected to enroll approximately 120 patients in the adjuvant setting and 40 patients with active disease at approximately 20 clinical sites."

They say they will have the first 20 enrolled by the end of 2021.

when is full enrollment 2022, 2023, 2030? and what the hell is taking so long?
The excuse in 2020 was covid shut down research and trials and blah blah.
Are Doctors NOT recommending Marker trials for AML and Pancreatic and if so, why?

You would think patients would be flocking to a therapy that supposedly works so well.